全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Teenagers as a Moving Target: How Can Teenagers Be Encouraged to Accept Treatment?

DOI: 10.3390/jpm2040277

Keywords: pediatric drugs, teenagers, packaging, design

Full-Text   Cite this paper   Add to My Lib

Abstract:

Pediatric patients exhibit their own needs and problems and are now considered as a real patient group in which downsizing the adult formulation is not the best choice and may result in problems. Adolescence (between 12 and 18 years) is a transitional period of life from puberty to adulthood and, in this pediatric subgroup population, complex problems are observed in compliance with chronic treatments. Heterogeneity exists in this group which follows very different and sometimes short trends and tendencies and where illness can be a problem leading to stigmatization. Influence of social environment as well as friends is complex in this period of life. Teenagers have to take care of themselves and be part of the treatment including all the features of the social code of this group. Particular attention has to be paid to formulation and packaging in order to increase compliance and to suit the specific needs of this pediatric subgroup. Some examples are given for different drug forms.

References

[1]  Gauthier, P.; Cardot, J.-M. Developing Drugs for Children and the Adjustment of Medication—Is It a New Challenge or an Adaptation of Past Ideas? J. Pers. Med. 2011, 1, 5–16, doi:10.3390/jpm1010005.
[2]  European Medicine Agency. Draft Guideline on Pharmaceutical Development of Medicines for Paediatric Use; European Medicine Agency: London, UK, 2011.
[3]  Tranches d'age en pédiatrie. Bulletin terminologique de l'industrie pharmaceutique. 2010, 21. Available online: http://www.groupetraduction.ca/documents/Vol21no12010.pdf (accessed on 4 December 2012). No. 1.
[4]  Gauthier, P. Teenagers, a moving target. Behaviour of teenagers about compliance how to induce compliance on this target. In 11th Pharmapack, Paris, France, 16 February 2012.
[5]  Chastellier, R. Marketing jeune; Village Mondial: Paris, France, 2003; p. 192.
[6]  Grosset, D. Les jeunes une cible difficile à séduire. Marketing Magazine, No. 145, Available online: http://www.e-marketing.fr/Marketing-Magazine/Article/Les-jeunes-une-cible-difficile-a-seduire-38394-1.htm/ (accessed on 4 December 2012).
[7]  Committee for Medicinal Product for Human Use (CMPH). Reflection Paper: Formulations of Choice for the Paediatric Population. European Medicines Agency (EMA): London, UK, 2006.
[8]  Matsui, D. Current issues in pediatric medication adherence. Pediatric Drugs 2007, 9, 283–288, doi:10.2165/00148581-200709050-00001.
[9]  Bauer, E.J. Pharmaceutical Packaging Handbook; Informa Healthcare: New York, NY, USA, 2009; p. 585.
[10]  Gauthier, P. Formulation and packaging design for NCE, examining specific population and product repositioning. Ther. Deliv. 2011, 2, 845–848, doi:10.4155/tde.11.46.
[11]  Gauthier, P. A drug more properly taken thanks to a more adapted design will prove more efficiency in 'transfert de connaissance, les entretiens de l'école de Design Nantes Atlantique. Available online: http://www.lecolededesign.com/ressources/CADI_hors_serie_2008.pdf (accessed on 4 December 2012).
[12]  Satkar, G. Why consumers select one brand over another—Creating emotional engagement with the consumers. In PackVision in Emballage 2010, Paris, France, 22–25 November 2010.
[13]  ClyckFolder—HCPC Europe. Available online: http://www.hcpc-europe.net/cms/.../Bayer_Folder.pdf (accessed on 4 December 2012).
[14]  Walsh, J.; Bickmann, D.; Breitkreutz, J.; Chariot-Goulet, M. European Paediatric Formulation Initiative (EuPFI). Delivery devices for the administration of paediatric formulations: Overview of current practice, challenges and recent developments. Int. J. Pharm. 2011, 415, 221–231, doi:10.1016/j.ijpharm.2011.05.048.
[15]  Cram, A.; Breitkreutz, J.; Desset-Brethes, S.; Nun, T.; Tuleu, C. European Paediatric Formulation Initiative (EuPFI). Challenges of developing palatable oral paediatric formulations. Int. J. Pharm. 2009, 365, 1–3.
[16]  Amcor TearStick?. Available online: http://www.amcor.com/products_services/amcor_safestick.html/ (accessed on 4 December 2012).
[17]  Ampoule Plastique UNICADOSE?. Available online: http://www.eskisspackaging.eu/ampoule_unicadose.asp?lg=fr/ (accessed on 4 December 2012).
[18]  ACP TWINPACK. Available online: http://www.acp.eu.com/fr/twinpack-18/ (accessed on 4 December 2012).
[19]  Easysnap. Available online: http://www.easysnap.com/why-easysnap/ (accessed on 4 December 2012).
[20]  Lameplast Group. Available online: http://www.lameplastgroup.com/Allegati/4B16CE0879BB4E7EBA3457B3CD211B1C.pdf (accessed on 4 December 2012).
[21]  Del Pouch? Single Dose Frangible Applicator (USA). Available online: http://www.globalpackagegallery.com/main.php/v/pharma/dell_pouch.jpg.html/ (accessed on 4 December 2012).
[22]  Seley, J.J. Is non-compliance a dirty word? Diabetes Educ. 1993, 19, 386–391, doi:10.1177/014572179301900504.
[23]  Timms, N.; Lowes, L. Autonomy or non-compliance in adolescent diabetes? Br. J. Nurs. 1999, 8, 794–800.
[24]  New app will allow diabetics to manage condition on their iPhone. Daily Mail Reporter, Available online: http://www.dailymail.co.uk/health/article-2113676/New-iPhone-app-iBGStar-device-allow-diabetics-manage-condition.html/ (accessed on 4 December 2012).
[25]  Easypod?—Growth Hormone Delivery Homepage, Available online: http://www.saizenus.com/ (accessed on 4 December 2012).
[26]  NovoPen? junior—Novonordisc France. Available online: http://www.novonordiskmedia.fr/documents/article_page/document/dispositif_medicaux_novopen.asp/ (accessed on 4 December 2012).

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133